ProfileGDS4718 / 241477_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 67% 57% 64% 59% 52% 53% 66% 57% 56% 59% 56% 58% 59% 54% 58% 57% 58% 59% 69% 68% 59% 58% 57% 58% 54% 57% 53% 62% 55% 58% 51% 63% 57% 55% 56% 56% 63% 64% 64% 56% 59% 53% 54% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1680461
GSM549102patient 115, normal, homogenized [OPG study]6.6201567
GSM549104patient 119, normal, homogenized [OPG study]5.926357
GSM549108patient 138, normal, homogenized [OPG study]6.4130364
GSM549119patient 077, normal, homogenized [OPG study]6.0392759
GSM549133patient 032, cancer, homogenized [OPG study]5.6081352
GSM549139patient 042, cancer, homogenized [OPG study]5.6626753
GSM549099patient 107, normal, homogenized [OPG study]6.5130466
GSM549109patient 139, normal, homogenized [OPG study]5.9288257
GSM549110patient 046, normal, homogenized [OPG study]5.8919556
GSM549114patient 063, normal, homogenized [OPG study]6.0181559
GSM549122patient 082, normal, homogenized [OPG study]5.8879656
GSM549134patient 033, cancer, homogenized [OPG study]5.9702258
GSM549136patient 036, cancer, homogenized [OPG study]6.0043359
GSM549140patient 044, cancer, homogenized [OPG study]5.7163254
GSM549111patient 047, normal, homogenized [OPG study]5.9822758
GSM549113patient 057, normal, homogenized [OPG study]5.8814357
GSM549132patient 031, cancer, homogenized [OPG study]5.9812758
GSM549137patient 038, cancer, homogenized [OPG study]6.0361259
GSM549142patient 047, cancer, homogenized [OPG study]6.7565469
GSM549100patient 110, normal, homogenized [OPG study]6.6992368
GSM549107patient 135, normal, homogenized [OPG study]6.0608259
GSM549115patient 068, normal, homogenized [OPG study]5.9927758
GSM549116patient 072, normal, homogenized [OPG study]5.9569457
GSM549120patient 078, normal, homogenized [OPG study]6.0051158
GSM549131patient 030, cancer, homogenized [OPG study]5.7325454
GSM549118patient 074, normal, homogenized [OPG study]5.9065357
GSM549129patient 027, cancer, homogenized [OPG study]5.7054653
GSM549123patient 088, normal, homogenized [OPG study]6.2384562
GSM549124patient 006, cancer, homogenized [OPG study]5.8575755
GSM549126patient 015, cancer, homogenized [OPG study]5.9827558
GSM549128patient 025, cancer, homogenized [OPG study]5.563751
GSM549103patient 117, normal, homogenized [OPG study]6.2985963
GSM549117patient 073, normal, homogenized [OPG study]5.8556857
GSM549138patient 041, cancer, homogenized [OPG study]5.8025955
GSM549141patient 045, cancer, homogenized [OPG study]5.8334656
GSM549130patient 028, cancer, homogenized [OPG study]5.8629556
GSM549101patient 111, normal, homogenized [OPG study]6.3238963
GSM549105patient 128, normal, homogenized [OPG study]6.430464
GSM549106patient 134, normal, homogenized [OPG study]6.4548764
GSM549112patient 048, normal, homogenized [OPG study]5.8799756
GSM549125patient 011, cancer, homogenized [OPG study]6.0336559
GSM549127patient 024, cancer, homogenized [OPG study]5.7017653
GSM549135patient 035, cancer, homogenized [OPG study]5.7025854